Annotation Detail for UBXN2A
Basic Information
Top
| Desease Name |
|---|
| quantitative traits |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of UBXN2A mRNA | decreases expression | 17888722
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.66 | 17418594 |
| MESH:D000419 |
Albuminuria |
|
Doxorubicin |
5.33 | 21441931 |
| MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
6.11 | 14601052 |
| MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.38 | 17150277 |
| MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.56 | 16115903 16595493 16096432 16322301 18234424 15692762 15668708 16935488 15939500 15994142 15136595 18382427 11325840 15634643 17983394 17426702 17369602 18695136 19526202 16826403 18628466 15567936 15993339 16264153 |
| MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
6.23 | 16051944 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
2.27 | 16234567 17876044 16023760 18059187 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.36 | 16201981 1485588 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.74 | 6189445 |
| MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.86 | 15476868 16269455 17519947 17382496 17007740 17351982 17329180 16278810 17131338 16731534 16364871 16612575 17308081 15811867 16109756 16242529 16952015 15792986 15505089 18627295 17924179 17974986 16651473 17928571 16455267 |
| MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.08 | 16243910 17334414 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.15 | 18259882 18802399 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
2.55 | 17416283 |
| MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
4.07 | 18602426 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.78 | 17359293 |
| MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
6.57 | 18037988 |
| MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
5.68 | 19069698 |
| MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.67 | 17150277 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.87 | 15692506 |
| MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.84 | 14766674 16144979 12587719 18674790 17888722 16707910 16330681 17875725 16879835 18006777 16244371 16495754 16244372 |
| MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.64 | 17481944 |
| MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.53 | 15692506 |
| MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.93 | 15147373 18501091 17606976 |
| MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.32 | 15369732 15699352 16775033 |
| MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.78 | 16707910 |
| MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
6.57 | 16085563 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.16 | 16595196 16439617 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
3.32 | 17085340 16842330 |
| MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.15 | 17418594 6189445 |
| MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.84 | 16098063 |
| MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
4.28 | 17654614 |
| MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
5.47 | 15621674 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.35 | 15458769 |
| MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.34 | 16827129 |
| MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.22 | 17638057 |
| MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
5.13 | 15792986 |
| MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.88 | 17415656 |
| MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.12 | 19429709 15857846 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.12 | 18259882 |
| MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.68 | 16899518 16636307 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.53 | 15640375 16889571 |
| MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.49 | 15555623 |
| MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.57 | 15930896 |
| MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
6.57 | 17983394 |
| MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
6.57 | 17638057 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.48 | 18437689 15897917 16868541 15749863 16729912 16888761 |
| MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
5.13 | 17922066 |
| MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.56 | 17203757 16767912 15675481 17710206 15625365 18313854 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
5.03 | 16326096 14601052 |
| MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.88 | 17846226 |
| MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
3.15 | 15692506 |
| MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
5.47 | 17203757 16767912 15625365 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.79 | 17909728 16010429 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
2.92 | 17653716 |
| MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
5.13 | 17638931 16364871 17678736 17334414 |
| Pathway ID |
Pathway Name |
|---|
| KEGG:04141 |
Protein processing in endoplasmic reticulum |
Related Pathway Information